Are Placebo-Controlled, Relapse Prevention Trials in Schizophrenia Research Still Necessary or Ethical?

被引：6
|
作者：
Lawrence, Ryan E. [1 ,2 ]
Appelbaum, Paul S. [2 ,3 ]
Lieberman, Jeffrey A. [1 ,2 ,3 ]
机构：
[1] New York Presbyterian Hosp, Dept Psychiat, New York, NY USA
[2] Columbia Univ, Dept Psychiat, Med Ctr, New York, NY USA
[3] New York State Psychiat Inst & Hosp, New York, NY 10032 USA
来源：
JAMA PSYCHIATRY | 2019年 / 76卷 / 07期
关键词：
MEDICATION;
D O I：
10.1001/jamapsychiatry.2019.0275
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
This Viewpoint discusses the implications of placebo-controlled, relapse prevention trials in schizophrenia research and suggests that continuing such trials may no longer be necessary or ethical.
引用
收藏
页码：673 / 674
页数：2
相关论文
共 50 条
  • [1] Placebo-controlled trials in schizophrenia: Are they ethical? Are they necessary?
    Weijer, C
    [J]. SCHIZOPHRENIA RESEARCH, 1999, 35 (03) : 211 - 218
  • [2] Placebo-controlled relapse prevention trials in unipolar depression
    Bech, P.
    [J]. EUROPEAN PSYCHIATRY, 2007, 22 : S50 - S50
  • [3] A historical review of placebo-controlled, relapse prevention trials in schizophrenia: The loss of clinical equipoise
    Lawrence, Ryan E.
    Appelbaum, Paul S.
    Lieberman, Jeffrey A.
    [J]. SCHIZOPHRENIA RESEARCH, 2021, 229 : 122 - 131
  • [4] Placebo-controlled trials in psychiatric research: An ethical perspective
    Miller, FG
    [J]. BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 707 - 716
  • [5] Narcotic analgesia for ventilated newborns: Are placebo-controlled trials ethical and necessary?
    Kennedy, KA
    Tyson, JE
    [J]. JOURNAL OF PEDIATRICS, 1999, 134 (02): : 127 - 129
  • [6] Ethical issues of placebo-controlled trials
    Ferdman, RM
    Church, JA
    [J]. JOURNAL OF PEDIATRICS, 1999, 134 (02): : 251 - 251
  • [7] Feasibility of reducing the duration of placebo-controlled trials in schizophrenia research
    McMahon, Robert P.
    Kelly, Deanna L.
    Boggs, Douglas L.
    Li, Lan
    Hu, Qiaoyan
    Davis, John M.
    Carpenter, William T., Jr.
    [J]. SCHIZOPHRENIA BULLETIN, 2008, 34 (02) : 292 - 301
  • [8] The scientific and ethical basis for placebo-controlled trials in depression and schizophrenia: an FDA perspective
    Laughren, TP
    [J]. EUROPEAN PSYCHIATRY, 2001, 16 (07) : 418 - 423
  • [9] Psychiatry - Are placebo-controlled drug trials ethical?
    Enserink, M
    [J]. SCIENCE, 2000, 288 (5465) : 416 - 416
  • [10] Placebo-controlled studies in depression:: necessary, ethical and feasible
    Baldwin, D
    Broich, K
    Fritze, J
    Kasper, S
    Westenberg, H
    Möller, HJ
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2003, 253 (01) : 22 - 28
12345